Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance

(2011) Ayesha B. Alvero et al.   CELL CYCLE

A Current Review of Targeted Therapeutics for Ovarian Cancer

(2010) Susana M. Campos et al.   Journal of Oncology

Therapy of Murine Pulmonary Aspergillosis with Antibody-Alliinase Conjugates and Alliin

(2009) E. Appel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Harnessing Competing Endocytic Pathways for Overcoming the Tumor-Blood Barrier: Magnetic Resonance Imaging and Near-Infrared Imaging of Bifunctional Contrast Media

(2009) Helena Sheikhet Migalovich et al.   CANCER RESEARCH

Nanoparticle-Delivered Suicide Gene Therapy Effectively Reduces Ovarian Tumor Burden in Mice

(2009) Y.-H. Huang et al.   CANCER RESEARCH

Targeting the EGF Receptor for Ovarian Cancer Therapy

(2009) Reema Zeineldin et al.   Journal of Oncology

A daidzein–daunomycin conjugate improves the therapeutic response in an animal model of ovarian carcinoma

(2008) Dalia Somjen et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Allicin inhibits cell growth and induces apoptosis through the mitochondrial pathway in HL60 and U937 cells

(2007) Talia Miron et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY